NasdaqGM - Nasdaq Real Time Price USD
CureVac N.V. (CVAC)
3.5100
-0.0800
(-2.23%)
As of 2:32:07 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | -0.19 | 0.09 | -0.46 | -0.34 |
| Low Estimate | -0.24 | -0.15 | -0.61 | -0.45 |
| High Estimate | -0.14 | 0.33 | -0.33 | -0.2 |
| Year Ago EPS | -0.31 | -0.32 | 0.72 | -0.46 |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 6 |
| Avg. Estimate | 3.34M | 34.59M | 66.69M | 108.62M |
| Low Estimate | -- | -- | -- | 61.2M |
| High Estimate | 12.8M | 125.55M | 127.21M | 158.53M |
| Year Ago Sales | 12.37M | 14.44M | 535.2M | 66.69M |
| Sales Growth (year/est) | -73.02% | 139.59% | -87.54% | 62.88% |
Earnings History
| Currency in EUR | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.26 | 1.41 | -0.09 |
| EPS Actual | -0.31 | -0.32 | 1.5 | -0.14 |
| Difference | -0.1 | -0.06 | 0.09 | -0.05 |
| Surprise % | -47.60% | -22.53% | 6.02% | -54.15% |
EPS Trend
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.19 | 0.09 | -0.46 | -0.34 |
| 7 Days Ago | -0.14 | -0.15 | -0.51 | -0.36 |
| 30 Days Ago | -0.16 | -0.14 | -0.5 | -0.36 |
| 60 Days Ago | -0.16 | -0.14 | -0.5 | -0.36 |
| 90 Days Ago | -0.16 | -0.14 | -0.5 | -0.36 |
EPS Revisions
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVAC | 38.97% | 127.58% | -164.57% | 26.31% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 4/30/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/14/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 9/16/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/16/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 7/3/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 4/25/2024 |
Related Tickers
ARCT Arcturus Therapeutics Holdings Inc.
11.06
-2.81%
BNTX BioNTech SE
93.63
-1.21%
VXRT Vaxart, Inc.
0.4165
+2.33%
CTMX CytomX Therapeutics, Inc.
1.0250
-5.96%
PBYI Puma Biotechnology, Inc.
2.9150
-5.05%
VIR Vir Biotechnology, Inc.
5.21
-3.79%
NVAX Novavax, Inc.
6.04
-9.38%
FOLD Amicus Therapeutics, Inc.
6.07
-0.16%
ABUS Arbutus Biopharma Corporation
3.2500
-1.52%
PRQR ProQR Therapeutics N.V.
1.6350
+5.48%